Log In
Print this Print this

Temodal, Temodar, temozolomide

  Manage Alerts
Collapse Summary General Information
Company Cancer Research Technology Ltd.
DescriptionImidazotetrazine cytotoxic alkylating agent
Molecular Target DNA
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationBrain cancer
Indication DetailsFirst-line treatment for newly diagnosed glioblastoma multiforme (GBM); Treat glioblastoma multiforme (GBM); Treat high-grade glioma; Treat malignant glioma; Treat newly diagnosed glioblastoma multiforme (GBM) and refractory malignant gliomas, such as anaplastic astrocytoma; Treat newly diagnosed glioblastoma multiforme (GBM) in combination with radiotherapy; Treat refractory anaplastic astrocytoma
Regulatory Designation


Merck & Co. Inc.

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today